CDRH Mulls Alternative Inspection Methods, Random-Sampling Audits

FDA expects to begin auditing randomly selected manufacturers of low risk devices by the first quarter of 2002, FDA staffers suggest following submission of the proposal to the Office of Regulatory Affairs.